Jonathan Schwarts
Company: Rocket Pharmaceuticals
Job title: Chief Medical Officer
Seminars:
Joint Q&A Session 12:30 pm
Have the speakers answer your questionsRead more
day: Day One
Autologous HSPC-targeted LV Gene Therapy for Fanconi Anemia & LAD-I: An Update From Rocket Pharmaceuticals 9:00 am
Specific challenges for cell- and gene-based therapy in life-threatening hematopoietic disorders. Fanconi anemia gene therapy program: updated results Leukocyte adhesion deficiency gene therapy program: updated resultsRead more
day: Day One